Pediatric Rheumatology

unofficial impact factor 1.74
Search for
Advanced search
Pediatric Rheumatology
Tools
Share this article
Open Access Highly Access

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial

Sudha Visvanathan, Carrie Wagner, Joseph C Marini, Daniel J Lovell, Alberto Martini, Ross Petty, Ruben Cuttica, Patricia Woo, Graciela Espada, Marco Gattorno, Maria T Apaz, Eileen Baildam, Anders Fasth, Valeria Gerloni, Pekka Lahdenne, Pierre Quartier, Rotraud Saurenmann, Suzanne Travers, Alan Mendelsohn, Stephen Xu, Edward H Giannini, Nicolino Ruperto*, the Paediatric Rheumatology INternational Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

Pediatric Rheumatology 2010, 8:24 doi:10.1186/1546-0096-8-24

Accesses  

  • Last 30 days: 67 accesses
  • Last 365 days: 893 accesses
  • All time: 2936 accesses

Cited by

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations